Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
01/21/2004 | EP1381267A2 Transgenic plants containing altered levels of steroid compounds |
01/21/2004 | EP1056466B1 Tadg-15: an extracellular serine protease overexpressed in breast and ovarian carcinomas |
01/21/2004 | EP0842276B1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv) |
01/21/2004 | EP0728213B1 Transgenic fructan accumulating crops and methods for their production |
01/21/2004 | EP0695349B1 Enzymes with xylanase activity from aspergillus aculeatus |
01/21/2004 | CN1469929A Method of modifying microorganism-origin transglutaminase |
01/21/2004 | CN1469928A Cytochrome P450 monooxygenases consisting of thermophilic bacteria |
01/21/2004 | CN1469927A Enhancemnet of industrial production by increasing substrate transport |
01/21/2004 | CN1469919A Laundry detergent compositions comprising mannosan enzyme and proteinase |
01/21/2004 | CN1468961A Expression and purification of soluble SARS virus 3CL proteinase |
01/21/2004 | CN1468960A Production process of human lysozyme as AIDS treating medicine with plant as bioreactor |
01/21/2004 | CN1468828A Organic fertilizer and its production process |
01/21/2004 | CN1135265C Enzyme-containing granules and process for producing thereof |
01/21/2004 | CN1135264C Process for producing L-methionine gamma-lyase crystals |
01/21/2004 | CN1135263C Process for producing pectinase of ramie degumming and its application in degumming of ramie |
01/20/2004 | US6680429 Starchless variety of pisum sativum having elevated levels of sucrose |
01/20/2004 | US6680428 Isolated nucleic acids encoding methylenetetrahydrofolate dehydrogenase enzymes |
01/20/2004 | US6680425 Chimeric plant promoters comprising sugar-regulatory sequences |
01/20/2004 | US6680424 Modified proteinase inhibitors |
01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
01/20/2004 | US6680369 Nucleotide sequences coding protein for use in treatment cytoskeletal defects |
01/20/2004 | US6680197 Breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, and t cells that are specific for cells expressing such polypeptides. |
01/20/2004 | US6680190 Gene encoding phosphoglucoisomerase |
01/20/2004 | US6680189 (a disintegrin and metalloprotease) adam proteins; preventing or treating disc herniation, ischialgia, glomerular nephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis or osteoporosis |
01/20/2004 | US6680188 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
01/20/2004 | US6680187 Nucleotide sequences coding for the PTSI protein |
01/20/2004 | US6680186 Nucleotide sequences which encode plsC gene |
01/20/2004 | US6680185 Plant polyphenol oxidase homologs |
01/20/2004 | US6680182 Promoter sequence operably linked to a dna sequence encoding first and second proteins linked by hinge regiion; tetanus toxin c fragments |
01/20/2004 | US6680171 Drug screening, genetic engineering |
01/20/2004 | US6680170 Polynucleotides encoding STE20-related protein kinases and methods of use |
01/20/2004 | CA2210753C Farnesyl diphosphate synthase |
01/20/2004 | CA2155332C Polypeptide having cold-stable pyruvate, orthophosphate dikinase activity, dna encoding the same and recombinant vector and transformed plants containing the dna |
01/20/2004 | CA2115414C Technique for extracorporeal treatment of blood |
01/20/2004 | CA2083027C Formation of protein microparticles by antisolvent precipitation |
01/15/2004 | WO2004005529A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
01/15/2004 | WO2004005527A1 Microorganisms and processes for enhanced production of pantothenate |
01/15/2004 | WO2004005526A1 Process for producing phorenol |
01/15/2004 | WO2004005519A1 Construction of a recombinant saccharomyces cerevisiae oenological yeast strain that overexpresses an endopolygalacturonase, which is intended for use in wine production |
01/15/2004 | WO2004005518A1 PURIFICATION, CLONING AND BIOCHEMICAL CHARACTERIZATION OF XendoU, ENDORIBONUCLEASIC ACTIVITY INVOLVED IN SMALL NUCLEAR RNA SPLICING-INDEPENDENT BIOSYNTHESIS IN XENOPUS LAEVIS |
01/15/2004 | WO2004005517A2 L-amidase from rhizobium huautlense |
01/15/2004 | WO2004005516A1 Use of ahas mutant genes as selection marker in potato transformation |
01/15/2004 | WO2004005511A1 Tumor-lysing virus growing selectively in tumor cells |
01/15/2004 | WO2004005504A1 Methods for obtaining pathogen resistance in plants |
01/15/2004 | WO2004005503A1 Milk-coagulating enzyme originating in bacterium and process for producing cheese using the same |
01/15/2004 | WO2004005501A1 Regulation of human casein kinase i epsilon |
01/15/2004 | WO2004005500A1 Novel polypeptide having function of 7-keto-8-aminopelargonic acid synthase of plant and method for inducing growth inhibition and lethality by suppressing expression of the polypeptide |
01/15/2004 | WO2004005499A1 Glucose dehydrogenase |
01/15/2004 | WO2004005487A2 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42 |
01/15/2004 | WO2004005485A2 Compositions and methods for controlling parasitic nematodes |
01/15/2004 | WO2004005483A2 ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
01/15/2004 | WO2004005482A2 Methods and compositions for the production, identification and purification of fusion proteins |
01/15/2004 | WO2004005475A2 Purified and isolated heparan sulfate 3-o-sulfotransferase isoform 5 nucleic acids and polypeptides and therapeutic and screening methods using same |
01/15/2004 | WO2004005473A2 Hcv fusion proteins with modified ns3 domains |
01/15/2004 | WO2004005471A2 Serine protease 16 |
01/15/2004 | WO2004005442A1 Method for the production of conjugated polyunsaturated fatty acids comprising at least two double bonds in plants |
01/15/2004 | WO2004005347A1 Thrombin-cleavable factor x analogues |
01/15/2004 | WO2004005317A2 Thrombin peptide derivative dimers |
01/15/2004 | WO2004005315A2 Pin1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design |
01/15/2004 | WO2004004785A1 Mchks as modifiers of the chk1 pathway and methods of use |
01/15/2004 | WO2004004698A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
01/15/2004 | WO2004004652A2 Mitotic kinesin binding site |
01/15/2004 | WO2004004495A1 Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
01/15/2004 | WO2004004451A1 Methods of screening compounds for grk6 modulating activity |
01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
01/15/2004 | WO2003074667A3 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells |
01/15/2004 | WO2003066866A3 Cultivation method of transgenic plants for lycopene cyclase |
01/15/2004 | WO2003062263A3 Aggrecanase-1 and -2 peptide substrates and methods |
01/15/2004 | WO2003060130A3 Pim-3 kinase as a target for type 2 diabetes mellitus |
01/15/2004 | WO2003050897A3 Biocompatible membranes of block copolymers and fuel cells produced therewith |
01/15/2004 | WO2003023048A3 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
01/15/2004 | WO2003020019A3 Methods and compositions for pearl oyster cultivation |
01/15/2004 | WO2003014383A3 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
01/15/2004 | WO2003012048A3 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
01/15/2004 | WO2002095032A3 Methods and compositions of human proteins and uses thereof. |
01/15/2004 | WO2002095013A3 Engineered bira for in vitro biotinylation |
01/15/2004 | WO2002083844A3 Compositions and methods for the production of betaine lipids |
01/15/2004 | WO2002072023A3 Production of high levels of transgenic factor viii with engineered stability, and its therapeutic uses |
01/15/2004 | US20040010822 Hydroperoxyde lyases |
01/15/2004 | US20040010821 Stress tolerance and delayed senescence in plants |
01/15/2004 | US20040010820 Transgenic corn which express ligninolytic enzymes for use in papermaking, waste treatment, bioremediation and pollution control |
01/15/2004 | US20040010819 Canola oil having increased oleic acid and decreased linolenic acid content |
01/15/2004 | US20040010818 Transgenic plants with a suppressed triterpene level |
01/15/2004 | US20040010817 Comprises enzymatic polypeptide for synthesis of fatty acids for use in industrial lubricants, plasticizers and surfactants; vegetable oils |
01/15/2004 | US20040010814 Comprises nucleotide sequences coding kinases for developing contraceptives and controlling sex determination in animals |
01/15/2004 | US20040010809 Modulation of cytochrome P450 reductase activity |
01/15/2004 | US20040010306 A gradual removal of injured and diseased tissue providing a multilayer form of treatment such as regeneration or preventing proliferation of body tissue; biodegradable; stents; patches |
01/15/2004 | US20040010134 Albumin fusion proteins |
01/15/2004 | US20040010133 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis and treatment of disease, drug screening, cosmetics and nutraceuticals |
01/15/2004 | US20040010120 Novel polypeptides and nucleic acids encoding same |
01/15/2004 | US20040009951 DNA deamination mediates innate immunity to (retro)viral infection |
01/15/2004 | US20040009948 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
01/15/2004 | US20040009922 A PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof |
01/15/2004 | US20040009914 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
01/15/2004 | US20040009911 Hepsin substrates and prodrugs |
01/15/2004 | US20040009898 Delivery vehicle construct comprising a cargo portion that is preferably a nucleic acid encoding a CFTR, and a u7-peptide portion. |
01/15/2004 | US20040009891 Method and composition for treating obesity by targeting cathepsin |
01/15/2004 | US20040009890 Structure-based design of a drug that can act as an inhibitor of at least two different biological entities using computer modeling; useful for designing HIV protease inhibitors and antineoplastic agents and where drug resistance may exist. |
01/15/2004 | US20040009613 Methods of identifying modulators of bromodomains |
01/15/2004 | US20040009603 Antiviral vectors |